About one month after the announcement of McNeil Consumer Healthcare's recall of children's liquid pain and allergy medications , the US Food and Drug Administration testified before the US House Committee on Oversight and Government Reform about the issue.
USP membership meeting prepared the standards-setting body to meet modern challenges.
Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.
Too much or too little control can actually lead to the same result.
The authors recommend a strategy for classifying similar nonstainless-steel surfaces into three groups based upon the analytical recovery that was observed in this study.
An effective quality management system will identify the root cause of non-conformances and put measures in place to ensure that they do not recur, but is the pharmaceutical industry choosing the right methods to make sure this happens?
Shared audits of suppliers offer several advantages, but networking to conduct such an audit can be challenging.
Genzyme (Cambridge, MA) signed a consent decree of permanent injunction that requires the company to correct manufacturing-quality violations at its Allston, Massachusetts, manufacturing facility.
More acquisitions are expected as the patent cliff pushes the pharma industry into a critical phase, with many executives believing that the industry will be unable to innovate sufficiently from within to replace blockbuster drugs.
Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its "Ten Principles on Counterfeit Medicines" last week to draw public attention to the issue.
The US Food and Drug Administration launched a program last week designed to "educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful."
Online process monitoring could help companies achieve the dual goals of ensuring high end-product quality and satisfying regulatory demands.
Effective May 1, 2010, the US Pharmacopeia has revised its Pending Monographs Guideline to clarify that excipients are eligible for pending-monograph status and can ultimately be included in an official National Formulary (NF) monograph.
Sundlof Resigns as FDA's Head of Food Safety; and More
In an effort to standardize quality agreements for active pharmaceutical ingredients in the drug industry, the Bulk Pharmaceuticals Task Force, an affiliate of the Society of Chemical Manufacturers and Affiliates, has developed a template to help manufacturers and customers comply with US regulatory requirements in a simplified manner.
The European Ombudsman has recommended that the European Medicines Agency review its refusal to grant public access to reports on adverse drug reactions.
Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More
McNeil Consumer Healthcare is voluntarily recalling all lots that have not yet expired of certain over-the-counter children's and infants' liquid products.
European Parliament Approves Proposals On Falsified Medicines and Pharmacovigilance; And More.
FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.
Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.
A method for determining sample size is finally getting some respect.
The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
